James Lightwood, PhD

Associate Professor

Clinical Pharmacy

Research program involves estimating the changes in direct healthcare costs due to changes in smoking behavior in large populations, and changes in exposure to passive smoking and health care cost and utilization attributable to adoption of smoke-free laws. Dr. Lightwood has done research in cost-benefit and cost-effectiveness analysis of disease prevention and management programs, cost savings attributable to smoking cessation, and the economics of infectious disease control

Publications:

The association of current exclusive e-cigarette use and dual use of e-cigarettes and cigarettes with psychological distress among U.S. adults.

Preventive medicine reports

Wang Y, Sung HY, Lea Watkins S, Lightwood J, Yao T, Max W

Smoking and healthcare expenditure reductions associated with the California Tobacco Control Program, 1989 to 2019: A predictive validation.

PloS one

Lightwood JM, Anderson S, Glantz SA

Healthcare utilisation and expenditures attributable to current e-cigarette use among US adults.

Tobacco control

Wang Y, Sung HY, Lightwood J, Yao T, Max WB

Abstract P250: The Impact of Recreational Cannabis Legalization on All-cause Hospitalizations and Acute Cardiovascular Event Hospitalizations in Colorado.

Circulation

Abra M Jeffers, James Lightwood, Salomeh Keyhani

Predictive validation and forecasts of short-term changes in healthcare expenditure associated with changes in smoking behavior in the United States.

PloS one

Lightwood J, Anderson S, Glantz SA

Estimating the long-run relationship between state cigarette taxes and county life expectancy.

Tobacco control

Baum A, Aguilar-Gomez S, Lightwood J, Bruzelius E, Glantz SA, Basu S

Healthcare Costs of Secondhand Smoke Exposure at Home for U.S. Children.

American journal of preventive medicine

Yao T, Sung HY, Wang Y, Lightwood J, Max W

Modelling the impact of a new tobacco product: review of Philip Morris International's Population Health Impact Model as applied to the IQOS heated tobacco product.

Tobacco control

Max WB, Sung HY, Lightwood J, Wang Y, Yao T

Healthcare Utilization and Expenditures Attributable to Smokeless Tobacco Use among US Adults.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco

Wang Y, Sung HY, Lightwood J, Chaffee BW, Yao T, Max W

Polytobacco Use and Nicotine Dependence Symptoms Among US Adults, 2012-2014.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco

Sung HY, Wang Y, Yao T, Lightwood J, Max W

Infrequent and Frequent Nondaily Smokers and Daily Smokers: Their Characteristics and Other Tobacco Use Patterns.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco

Wang Y, Sung HY, Yao T, Lightwood J, Max W

Health Care Utilization and Expenditures Attributable to Cigar Smoking Among US Adults, 2000-2015.

Public health reports (Washington, D.C. : 1974)

Wang Y, Sung HY, Yao T, Lightwood J, Max W

Healthcare costs attributable to secondhand smoke exposure at home for U.S. adults.

Tobacco induced diseases

Tingting Yao, Hai-Yen Sung, Yingning Wang, James Lightwood, Wendy Max

Healthcare costs attributable to secondhand smoke exposure at home for U.S. adults.

Preventive medicine

Yao T, Sung HY, Wang Y, Lightwood J, Max W

Relationship between spending on electronic cigarettes, 30-day use, and disease symptoms among current adult cigarette smokers in the U.S.

PloS one

Yao T, Max W, Sung HY, Glantz SA, Goldberg RL, Wang JB, Wang Y, Lightwood J, Cataldo J

PHP10 Interrupted Time Series Analysis Evaluating The Impact of A Pro-Generic Policy on Drug Pricing and Utilization In Argentina.

Value in Health

L Wilson, EJ Yi, J Lightwood, B Lee, U Garay

Factors associated with short-term transitions of non-daily smokers: socio-demographic characteristics and other tobacco product use.

Addiction (Abingdon, England)

Wang Y, Sung HY, Yao T, Lightwood J, Max W

Smoking Behavior and Healthcare Expenditure in the United States, 1992-2009: Panel Data Estimates.

PLoS medicine

Lightwood J, Glantz SA

Sociodemographic Differences Among U.S. Children and Adults Exposed to Secondhand Smoke at Home: National Health Interview Surveys 2000 and 2010.

Public health reports (Washington, D.C. : 1974)

Yao T, Sung HY, Wang Y, Lightwood J, Max W

Improved Label and Liver Warning for Nonprescription Acetaminophen Products.

Therapeutic innovation & regulatory science

Soller RW, Ho T, Lightwood JM

Polytobacco Use of Cigarettes, Cigars, Chewing Tobacco, and Snuff Among US Adults.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco

Sung HY, Wang Y, Yao T, Lightwood J, Max W

Health benefits of reducing sugar-sweetened beverage intake in high risk populations of California: results from the cardiovascular disease (CVD) policy model.

PloS one

Mekonnen TA, Odden MC, Coxson PG, Guzman D, Lightwood J, Wang YC, Bibbins-Domingo K

PHP5 Argentina’s Generic Drug Law: Was It Successful?.

Value in Health

B. Lee, O.U. Garay, J. Goldhaber-Fiebert, J. Tang, J. Lightwood, L.S. Wilson

Pharmacy students teaching prescribers strategies to lower prescription drug costs for underserved patients.

Journal of managed care pharmacy : JMCP

Stebbins MR, Frear ME, Cutler TW, Lightwood JM, Fingado AR, Lai CJ, Lipton HL

The effect of the California tobacco control program on smoking prevalence, cigarette consumption, and healthcare costs: 1989-2008.

PloS one

Lightwood J, Glantz SA

Corrigendum: Improvement of the Drug Allergy Alert for Nonprescription NSAIDs.

Therapeutic innovation & regulatory science

R.W. Soller, C. Shaheen, J. Yen, J. Rose, J. Lightwood

Improvement of the Drug Allergy Alert for Nonprescription NSAIDs.

Therapeutic innovation & regulatory science

R. William Soller, Christopher Shaheen, Jennifer Yen, John Rose, James Lightwood

The impact of changes in tobacco control funding on healthcare expenditures in California, 2012-2016.

Tobacco control

Max W, Sung HY, Lightwood J

Association between smokefree laws and voluntary smokefree-home rules.

American journal of preventive medicine

Cheng KW, Glantz SA, Lightwood JM

Evaluation of value-based insurance design with a large retail employer.

The American journal of managed care

Kim YA, Loucks A, Yokoyama G, Lightwood J, Rascate K, Serxner SA

The impact of the aging population on coronary heart disease in the United States.

The American journal of medicine

Odden MC, Coxson PG, Moran A, Lightwood JM, Goldman L, Bibbins-Domingo K

Effect of the Arizona tobacco control program on cigarette consumption and healthcare expenditures.

Social science & medicine (1982)

Lightwood J, Glantz S

Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease.

Obstetrical & Gynecological Survey

Kirsten Bibbins-Domingo, Glenn M. Chertow, Pamela G. Coxson, Andrew Moran, James M. Lightwood, Mark J. Pletcher, Lee Goldman

Projected effect of dietary salt reductions on future cardiovascular disease.

The New England journal of medicine

Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L

Black box warning contraindicated comedications: concordance among three major drug interaction screening programs.

The Annals of pharmacotherapy

Wang LM, Wong M, Lightwood JM, Cheng CM

Forecasting the future economic burden of current adolescent overweight: an estimate of the coronary heart disease policy model.

American journal of public health

Lightwood J, Bibbins-Domingo K, Coxson P, Wang YC, Williams L, Goldman L

Search form

You are here

James Lightwood, PhD

Research